Travere Therapeutics to Report Third Quarter 2022 Financial Results

Rhea-AI Summary

Travere Therapeutics (NASDAQ: TVTX) will report its third quarter 2022 financial results on October 27, 2022, after market close. A conference call and webcast will follow at 4:30 p.m. ET to discuss the results and provide a general business update. Investors can access the call via dial-in numbers or through a live webcast on the company's website, with a replay available post-event. Travere focuses on developing treatments for patients with rare diseases, aiming to address urgent treatment needs through collaboration with the rare disease community.

SAN DIEGO, Oct. 20, 2022 (GLOBE NEWSWIRE) -- Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced it will report third quarter 2022 financial results on Thursday, October 27, 2022, after the close of the U.S. financial markets. The Company will host a conference call and webcast to discuss the financial results and provide a general business update at 4:30 p.m. ET.

Conference Call Information

Date:	Thursday, October 27, 2022
Time:	4:30 p.m. ET
Dial-in numbers:	+1 (888) 394-8218 (U.S.) or +1 (323) 794-2551 (International)
Confirmation code:	3327353
Live webcast:	Travere.com in the “Events & Presentations” section of the “Investors” page

A replay of the webcast will be available approximately two hours after the live event and remain archived for approximately 90 days on the Company’s website.

About Travere Therapeutics

At Travere Therapeutics, we are in rare for life. We are a biopharmaceutical company that comes together every day to help patients, families and caregivers of all backgrounds as they navigate life with a rare disease. On this path, we know the need for treatment options is urgent – that is why our global team works with the rare disease community to identify, develop and deliver life-changing therapies. In pursuit of this mission, we continuously seek to understand the diverse perspectives of rare patients and to courageously forge new paths to make a difference in their lives and provide hope – today and tomorrow. For more information, visit travere.com

Contact:
Investor Relations
888-969-7879                                        
IR@travere.com

FAQ

When will Travere Therapeutics report its Q3 2022 financial results?

Travere Therapeutics will report its Q3 2022 financial results on October 27, 2022, after the market closes.

What time is the conference call for Travere Therapeutics' Q3 earnings?

The conference call for Travere Therapeutics' Q3 earnings is scheduled for 4:30 p.m. ET on October 27, 2022.

How can I access the webcast for Travere Therapeutics' Q3 earnings call?

You can access the webcast for Travere Therapeutics' Q3 earnings call on their website in the 'Events & Presentations' section.

Will there be a replay available for the Travere Therapeutics Q3 earnings call?

Yes, a replay of the webcast will be available approximately two hours after the live event and will remain archived for 90 days.